AIM
BIIB icon

Alhambra Investment Management’s Biogen BIIB Stock Holding History

Alhambra Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,219
Closed -$833K – 162
2023
Q4 		$833K Sell
3,219
-724
-18% -$178K 0.49% 52
2023
Q3 		$1.01M Sell
3,943
-236
-6% -$63.1K 0.67% 43
2023
Q2 		$1.19M Sell
4,179
-21
-0.5% -$6.25K 0.79% 32
2023
Q1 		$1.17M Buy
4,200
+113
+3% +$31.3K 0.8% 31
2022
Q4 		$1.13M Sell
4,087
-848
-17% -$240K 0.82% 33
2022
Q3 		$1.32M Buy
4,935
+181
+4% +$38.4K 1% 28
2022
Q2 		$970K Buy
4,754
+155
+3% +$31.7K 0.7% 36
2022
Q1 		$969K Buy
4,599
+586
+15% +$127K 0.64% 40
2021
Q4 		$963K Buy
4,013
+882
+28% +$227K 0.67% 38
2021
Q3 		$886K Buy
3,131
+200
+7% +$65.5K 0.68% 41
2021
Q2 		$1.01M Buy
2,931
+42
+1% +$12.7K 0.76% 32
2021
Q1 		$808K Buy
2,889
+1,150
+66% +$310K 0.65% 38
2020
Q4 		$426K Sell
1,739
-19
-1% -$4.9K 0.45% 77
2020
Q3 		$499K Buy
+1,758
New +$490K 0.6% 52

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alhambra Investment Management's BIIB Position: Q1 2024 in Review

Alhambra Investment Management sold out of Biogen (BIIB) in Q1 2024, closing a stake of 3,219 shares — an estimated $833K sold.

Alhambra Investment Management first reported a position in BIIB in Q3 2020 and held it in 14 quarters. The position peaked at $1.32M in Q3 2022. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Alhambra Investment Management reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Alhambra Investment Management sold 3,219 Biogen shares in Q1 2024, an estimated $833K.
  • Alhambra Investment Management first reported a position in Biogen in Q3 2020 and held it in 14 quarters.
  • Alhambra Investment Management's Biogen position peaked at $1.32M in Q3 2022.
  • 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Alhambra Investment Management's 13F filing for Q1 2024, filed 15 Apr 2024.